Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1893-1898

  Gladue, R P ^a   Carroll, L A ^a   Milici, A J ^a   Scampoli, D N ^a   Stukenbrok, H A ^a   Pettipher, E R ^a   Salter, E D ^a   Contillo, L ^a   Showell, H J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE B4; 1 [3 (4 BIPHENYLYLMETHYL) 4 HYDROXYCHROMAN 7 YL]CYCLOPENTANECARBOXYLIC ACID; BENZOPYRAN DERIVATIVE; CARBOXYLIC ACID; LEUKOTRIENE B4 RECEPTOR; OLIGOPEPTIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CELL INFILTRATION; CELL MIGRATION; CELL SPECIFICITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; EFFECTOR CELL; HISTOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; AMINO ACID SEQUENCE; ANIMAL; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; EOSINOPHIL; FEMALE; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE STRAIN; PARALYSIS; PASSIVE IMMUNIZATION; PATHOLOGY; SPINAL CORD; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; BENZOPYRANS; CARBOXYLIC ACIDS; CELL MOVEMENT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EOSINOPHILS; FEMALE; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PARALYSIS; RECEPTORS, LEUKOTRIENE B4; SPINAL CORD; T-LYMPHOCYTES;

EID: 0029665820     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1893     Document Type: Article

References (25)

1. Martin, R., and H.F. McFarland. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32:121-182.
2. Hafler, D.A., and H.L. Weiner. 1995. Immunological mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144: 75-107.
3. Scolding, N.J., J.P. Zajicek, N. Wood, and D.A.S. Compston. 1994. The pathogenesis of demyelinating disease. Prog. Neurobiol. 43:143-173.
4. Sriram, S., L. Carroll, S. Fortin, S. Cooper, and G. Ranges. 1988. In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis. J. Immunol. 141: 464-468.
5. Renno, T., M. Krakowski, C. Piccirillo, J. Lin, and T. Owens. 1995. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of experimental allergic encephalomyelitis: regulation by TH1 cytokines. J. Immunol. 154:944-953.
6. Godiska, R., D. Chantry, G.N. Dietsch, and P.W. Gray. 1995. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:167-176.
7. 4 in the immune system. Int. J. Immunopharmacol. 14: 441-449.
8. 4. Proc. Natl. Acad. Sci. USA. 79:7866-7870.
9. Neu, I., J. Mallinger, A. Wildfeuer, and L. Mehlber. 1992. Leukotrienes in the cerebrospinal fluid of multiple sclerosis patients. Acta Neural. Scand. 86:586-587.
10. Prosiegel, M., I. Neu, A. Wildfeuer, and G. Ruhenstroth-Bauer. 1989. Suppression of autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition. Acta Neurol. Scand. 79:223-226.
11. 4 on eosinophil infiltration in response to C5a in guinea pig skin. Br. J. Pharmacol. 113:117-120.
12. 4 and platelet activating factor in patients with inflammatory dermatoses. Clin. Exp. Immunol. 56:486-492.
13. 4 receptor antagonist CP-105,696. J. Pharmacol. Exp. Ther. 273:176-184.
14. 4 plays a critical role in the progression of collagen-induced arthritis. Proc. Natl. Acad. Sci. USA. 92:517-521.
15. 4 antagonist with oral activity in the murine collagen-induced arthritis model. J. Med. Chem. 37:3197-3199.
16. Su, X., and S. Sriram. 1992. Analysis of TCR Vβ gene usage and encephalogenicity of myelin basic peptide p91-103 reactive T cell clones in SJL mice: lack of evidence for V gene hypothesis. Cell. Immunol. 141:485-495.
17. Sriram, S., and L. Carroll. 1991. Haplotype-specific inhibition of homing of radiolabeled lymphocytes in experimental allergic encephalomyelitis following treatment with anti-IA antibodies. Cell. Immunol. 135:222-231.
18. 1-sensitized guinea-pigs: eosinophil peroxidase as a simple marker for detecting eosinophils in bronchioalveolar lavage fluid. J. Pharmacol. Exp. Ther. 264:922-929.
19. Lukacs, N.W., R.M. Strieter, C.L. Shaklee, S.W. Chensue, and S.L. Kunkel. 1995. Macrophage inflammatory protein-1α influences eosinophil recruitment in antigen-specific airway inflammation. Eur. J. Immunol. 25:245-251.
20. Meurer, R., G.V. Riper, W. Feeney, P. Cunningham, D. Hora, Jr., M.S. Springer, D.E. MacIntyre, and H. Rosen. 1993. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1α, or human interleukin 8. J. Exp. Med. 178:1913-1921.
21. Karpus, W.J., N.E. Lukacs, B.L. McRae, R.M. Stricter, S.L. Kunkel, and S.D. Miller. 1995. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155: 5003-5010.
22. Snead, O.C., and S.M. Kalavsky. 1976. Cerebrospinal fluid eosinophilia: a manifestation of a disorder resembling multiple sclerosis in childhood. J. Pediatr. 89:83-84.
23. Tanphaichitr, K. 1980. Multiple sclerosis associated with eosinophilic vasculitis, pericarditis, and hypocomplementemia. Arch. Neurol. 37:314-315.
24. Allsopp, G., S. Roters, and J.L. Turk. 1980. Isolation and characterization of the inflammatory infiltrate in the central nervous system of the guinea pig with experimental allergic encephalomyelitis. Neuropathol. Appl. Neurobiol. 6:109-118.
25. Durack, D.T., S.M. Sumi, and S.J. Klebanoff. 1979. Neurotoxicity of human eosinophils. Proc. Natl. Acad. Sci. USA. 76: 1443-1447.